Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank67
3Y CAGR+32.2%
5Y CAGR+35.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+32.2%/yr
Annual compound
5Y CAGR
+35.1%/yr
Consistent
Percentile
P67
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $197.08M | +57.7% |
| 2024 | $124.97M | -45.9% |
| 2023 | $230.78M | +170.7% |
| 2022 | $85.26M | -70.0% |
| 2021 | $284.31M | +550.2% |
| 2020 | $43.73M | +60.0% |
| 2019 | $27.33M | - |